# FDA recall D-1007-2022

> **Mckesson Medical-Surgical Inc. Corporate Office** · Class II · drug recall initiated 2022-04-13.

## Product

Sumatriptan Injection, USP, 6mg/0.5 mL, packaged in a box of 5 x 0.5 mL single-dose vials, Rx only, Manufacturer: Auromedics Pharma LLC, NDC 55150-0173-01

## Reason for recall

cGMP deviations: Temperature abuse

## Distribution

USA nationwide.

## Key facts

- **Recall number:** D-1007-2022
- **Recalling firm:** Mckesson Medical-Surgical Inc. Corporate Office
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-04-13
- **Report date:** 2022-06-15
- **Termination date:** 2023-11-30

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Richmond, VA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1007-2022

## Citation

> AI Analytics. FDA recall D-1007-2022. Retrieved 2026-05-31 from https://api.ai-analytics.org/recall/D-1007-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*